Cargando…

The biological basis and clinical symptoms of CAR-T therapy-associated toxicites

Currently, immunotherapy is attracting a lot of attention and may potentially become a leading approach in the treatment of cancer. One emerging therapeutic, the chimeric-antigen receptor T-cell adoptive immunotherapy (CAR-T) is showing remarkable efficacy in the treatment of several B-cell malignan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Titov, Aleksei, Petukhov, Alexey, Staliarova, Alena, Motorin, Dmitriy, Bulatov, Emil, Shuvalov, Oleg, Soond, Surinder M., Piacentini, Mauro, Melino, Gerry, Zaritskey, Andrey, Barlev, Nickolai A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123453/ https://www.ncbi.nlm.nih.gov/pubmed/30181581 http://dx.doi.org/10.1038/s41419-018-0918-x

Ejemplares similares

Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials
por: Smirnov, Sergei, et al.
Publicado: (2021)

Linking Metabolic Reprogramming, Plasticity and Tumor Progression
por: Shuvalov, Oleg, et al.
Publicado: (2021)

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
por: Titov, Aleksei, et al.
Publicado: (2020)

Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021)

Knowns and Unknowns about CAR-T Cell Dysfunction
por: Titov, Aleksei, et al.
Publicado: (2022)

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
por: Shuvalov, Oleg, et al.
Publicado: (2017)

Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells
por: Shuvalov, Oleg, et al.
Publicado: (2020)

Toxicité cutanée à l'erlotinib
por: Bourra, Hayat, et al.
Publicado: (2013)

Immunosuppressants: Various toxicites: case report
Publicado: (2021)

Toxicité systémique des anesthésiques locaux
por: Antel, Ryan, et al.
Publicado: (2022)

The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase
por: Daks, Alexandra, et al.
Publicado: (2021)

Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
por: Semenov, Oleg, et al.
Publicado: (2022)

Attenuation of p53 mutant as an approach for treatment Her2-positive cancer
por: Fedorova, Olga, et al.
Publicado: (2020)

p53-Independent Effects of Set7/9 Lysine Methyltransferase on Metabolism of Non-Small Cell Lung Cancer Cells
por: Daks, Alexandra, et al.
Publicado: (2021)

DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity
por: Moiseeva, Tatiana N., et al.
Publicado: (2013)

Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors
por: Bulatov, Emil, et al.
Publicado: (2018)

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
por: Zmievskaya, Ekaterina, et al.
Publicado: (2021)

The Role of Lysine Methyltransferase SET7/9 in Proliferation and Cell Stress Response
por: Daks, Alexandra, et al.
Publicado: (2022)

The Role of PTEN in Epithelial–Mesenchymal Transition
por: Fedorova, Olga, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
por: Piacentini, Mauro, et al.
Publicado: (2018)

Multiple drugs: Various toxicites and off-label use: case report
Publicado: (2020)

Distinct p63 and p73 Protein Interactions Predict Specific Functions in mRNA Splicing and Polyploidy Control in Epithelia
por: Rozenberg, Julian M., et al.
Publicado: (2020)

The Role of E3 Ligase Pirh2 in Disease
por: Daks, Alexandra, et al.
Publicado: (2022)

Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells
por: Shuvalov, Oleg, et al.
Publicado: (2021)

Toxicité au méthotrexate au cours d'une leucémie aiguë lymphoblastique
por: Lamchahab, Mouna, et al.
Publicado: (2014)

Methyltransferase Set7/9 as a Multifaceted Regulator of ROS Response
por: Daks, Alexandra, et al.
Publicado: (2023)

Case Report: Primary Leptomeningeal Medulloblastoma in a Child: Clinical Case Report and Literature Review
por: Morgacheva, Daria, et al.
Publicado: (2022)

The 26S proteasome is a multifaceted target for anti-cancer therapies
por: Grigoreva, Tatyana A, et al.
Publicado: (2015)

Phytochemicals Target Multiple Metabolic Pathways in Cancer
por: Shuvalov, Oleg, et al.
Publicado: (2023)

KMT Set7/9 affects genotoxic stress response via the Mdm2 axis
por: Lezina, Larissa, et al.
Publicado: (2015)

Principes et méthodes d'évaluation de la toxicité des produits chimiques, V.1
por: World Health Organization. Geneva
Publicado: (1979)

Observation d’une toxicité chronique au lithium chez une femme de 54 ans
por: Kobylianskii, Jane, et al.
Publicado: (2021)

E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells
por: Daks, Alexandra, et al.
Publicado: (2016)

Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
por: Valiullina, Aigul Kh., et al.
Publicado: (2023)

Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line
por: Valiullina, Aigul Kh., et al.
Publicado: (2023)

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells
por: Shuvalov, Oleg, et al.
Publicado: (2023)

Genome-editing tools for stem cell biology
por: Vasileva, E A, et al.
Publicado: (2015)

Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB
por: Aksenova, Vasilisa, et al.
Publicado: (2013)

Erratum: Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB
por: Aksenova, Vasilisa, et al.
Publicado: (2018)

SEMG1/2 augment energy metabolism of tumor cells
por: Shuvalov, Oleg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rfspqn8bdb3atnltnhlv7opj66